Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
HanAll's Licensed Partner in China Enters Sublicense Agreement with CSPC to Further Accelerate Development of Batoclimab 2022-10-11 19:00
Samsung Biologics unlocks additional capacity for production at its newest Plant 4 2022-10-11 19:00
Antengene Announces Upcoming Presentations at the 2022 Society for Immunotherapy of Cancer Annual Meeting 2022-10-08 10:43
First patient treated in Clarity's therapeutic prostate cancer trial 2022-10-07 21:06
HanAll's Second FcRn Inhibitor HL161ANS to be Added to the Development Program of its Licensed Partner 2022-10-04 19:00
Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry 2022-10-04 14:00
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022 2022-09-29 19:00
NeuShen Therapeutics Closes Pre-A Financing with ~$20M 2022-09-29 17:50
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC 2022-09-29 14:22
GC Labs becomes the first Korean laboratory to obtain certification of CDC standardization programs (VDSCP & HoSt) 2022-09-29 08:17
First-Ever Spinal Surgical Hand-held Robot by Point Robotics MedTech to Make Its Worldwide Debut in the United States 2022-09-28 21:01
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts 2022-09-28 19:00
Portfolio Highlights: Clinical and Financial Updates of ABM, F5, AceLink, HAYA, Regenacy, and Arthrosi 2022-09-28 18:31
The 6th China (Shenzhen) Innovation & Entrepreneurship International Competition Eindhoven, Netherlands Division is Open for Registration 2022-09-28 17:55
Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-09-27 21:40
Bioheng Biotech Announces Publication of Impressive Results with CD7-targeted allogeneic CAR-T cell therapy for Relapsed or Refractory T Cell Malignancies 2022-09-26 21:00
PharmAbcine to Participate in BIO-Europe 2022 2022-09-26 20:00
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility 2022-09-26 20:00
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy 2022-09-26 12:31
Ascentage Pharma Announces Phase I/II Data of Olverembatinib (HQP1351) Published in the Journal of Hematology & Oncology, Further Validating the Drug's Best-in-Class Potential 2022-09-21 22:49
1 68 69 70 71 72 220